Gilead Pill Can Prevent HIV in Heterosexuals, CDC Guidelines Say

Gilead Sciences Inc.’s anti-AIDS pill Truvada safely and effectively reduces the risk of HIV for healthy people having sexual intercourse, according to the first U.S. Centers for Disease Control and Prevention guidelines on using the drugs for prevention in heterosexuals.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.